Baystate Wealth Management LLC Candel Therapeutics, Inc. Transaction History
Baystate Wealth Management LLC
- $1.36 Billion
- Q4 2023
A detailed history of Baystate Wealth Management LLC transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Baystate Wealth Management LLC holds 76,910 shares of CADL stock, worth $476,842. This represents 0.01% of its overall portfolio holdings.
Number of Shares
76,910
Previous 97,310
20.96%
Holding current value
$476,842
Previous $89,000
26.97%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CADL
# of Institutions
22Shares Held
3.86MCall Options Held
0Put Options Held
0-
Northpond Ventures, LLC1.94MShares$12 Million8.58% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA812KShares$5.03 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA541KShares$3.36 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA146KShares$903,3770.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX82.6KShares$512,0890.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $179M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...